Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H56:IC31 for Prevention of Mtb Infection in Adolescents
NCT03265977Phase 2Withdrawn
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Jun 2018
- Primary completion
- Apr 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of AERAS-456 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Planned start Jun 2018; status: withdrawn.
02
Drugs
AERAS-456
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03265977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265977.